27 July 2020>: Database Analysis
Fibrinogen-Like Protein 2 (FGL2) is a Novel Biomarker for Clinical Prediction of Human Breast Cancer
Yanyan Feng 1AC* , Chunguang Guo 2BC* , Hesong Wang 1B , Lu Zhao 1CF , Wei Wang 1C , Ting Wang 1BC , Yuyin Feng 3C , Kai Yuan 1BCDF* , Guangrui Huang 3AEG*DOI: 10.12659/MSM.923531
Med Sci Monit 2020; 26:e923531
Table 1 Association of FGL2 with the clinical pathological characteristics of breast cancer patients derived from the TCGA database.
Variables | Clinical pathological | Number | Mean±SD | P |
---|---|---|---|---|
Sex | Female | 1091 | 2.89±1.06 | 0.004 |
Male | 12 | 2.00±0.89 | ||
Radiation therapy | No | 439 | 2.77±1.05 | 0.004 |
Yes | 553 | 2.96±1.05 | ||
Age | 589 | 2.89±1.07 | 0.713 | |
≥60 | 513 | 2.86±1.04 | ||
HER2 status | Negative | 290 | 2.92±1.01 | 0.496 |
Positive | 69 | 2.83±0.95 | ||
ER status | Negative | 212 | 2.87±1.18 | 0.458 |
Positive | 727 | 2.93±1.01 | ||
PR status | Negative | 308 | 2.79±1.13 | 0.013 |
Positive | 628 | 2.98±1.00 | ||
T stage | T1 | 281 | 3.02±1.04 | 0.038 |
T2 | 641 | 2.83±1.07 | ||
T3 | 138 | 2.93±1.06 | ||
T4 | 40 | 2.58±0.94 | ||
N stage | N0 | 519 | 2.88±1.11 | 0.28 |
N1 | 366 | 2.85±1.01 | ||
N2 | 120 | 2.95±1.03 | ||
N3 | 78 | 3.07±0.94 | ||
M stage | M0 | 917 | 2.87±1.06 | 0.134 |
M1 | 22 | 2.53±0.93 | ||
TNM stage | I | 182 | 3.00±1.08 | 0.055 |
II | 628 | 2.83±1.84 | ||
III | 250 | 2.95±1.00 | ||
IV | 20 | 2.45±0.95 |